Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Sintx Technologies, Inc. specializes in the development of advanced ceramic materials for medical devices, particularly in the orthopedic and dental markets. The company leverages its proprietary silicon nitride technology, which offers unique antimicrobial properties, setting it apart from traditional materials used in implants and surgical instruments.
Sintx generates revenue through the sale of its proprietary silicon nitride-based medical devices, which command premium pricing due to their advanced properties. The company has established partnerships with leading medical device manufacturers, enhancing its market reach and credibility.
Regulatory approvals for new products, particularly in the orthopedic sector
Partnership announcements with major medical device companies
Market adoption rates of silicon nitride technology in surgical applications
Changes in reimbursement policies affecting medical device pricing
Technological disruption from alternative materials or methods in medical devices
Regulatory changes that could delay product approvals or increase compliance costs
Emerging competitors developing similar or superior materials
Price competition from established players in the orthopedic and dental markets
High debt-to-equity ratio (3.61) raises concerns about financial stability
Negative operating cash flow and free cash flow could limit growth opportunities
moderate - The demand for medical devices is somewhat insulated from economic downturns, but significant recessions could impact elective surgeries and spending on healthcare.
Higher interest rates could increase Sintx's financing costs, affecting its ability to fund R&D and operations, which may lead to a compression of valuation multiples.
minimal - Sintx's current debt levels are manageable, but high leverage could become a concern if cash flows do not improve.
growth - Investors looking for high-risk, high-reward opportunities in innovative medical technology.
high - Sintx's stock has shown significant price fluctuations, reflecting its operational challenges and market sentiment.
